Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Exelon & HUGE GROWING UNMET NEED

<< Previous

Bullboard Posts

Next >>

Comment by porksnifferon Jun 01, 2021 3:24pm

71 Views

Post# 33304540

RE:RE:RE:RE:RE:RE:RE:Exelon & HUGE GROWING UNMET NEED

Market up 300 points, this turd? Nothing loolllll

Where are all the 'value' investors taking positions on the 'good value'??? All silent, all gone missing. Doesn't feel too good. You could have put your money anywhere and come out way ahead. Enjoy your losses and dead money.

Remember folks, one of the worst performing companies in Canada the past 3-5 years. Market has more than doubkled this has dropped 35%. Underperformed the index by 75 points as per charts I posted few weeks back. Yet the fraudsters here still trying to suck in noobs. Sad.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks